Cargando…
Disease-modifying effects of phosphocitrate and phosphocitrate-β-ethyl ester on partial meniscectomy-induced osteoarthritis
BACKGROUND: It is believed that phosphocitrate (PC) exerts its disease-modifying effects on osteoarthritis (OA) by inhibiting the formation of crystals. However, recent findings suggest that PC exerts its disease-modifying effect, at least in part, through a crystal-independent action. This study so...
Autores principales: | Sun, Yubo, Haines, Nikkole, Roberts, Andrea, Ruffolo, Michael, Mauerhan, David R., Mihalko, Kim L., Ingram, Jane, Cox, Michael, Hanley, Edward N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588234/ https://www.ncbi.nlm.nih.gov/pubmed/26424660 http://dx.doi.org/10.1186/s12891-015-0724-x |
Ejemplares similares
-
Expression of Phosphocitrate-Targeted Genes in Osteoarthritis Menisci
por: Sun, Yubo, et al.
Publicado: (2014) -
Biological Effects of Phosphocitrate on Osteoarthritic Articular Chondrocytes
por: Sun, Yubo, et al.
Publicado: (2017) -
Phosphocitrate Is Potentially a Disease-Modifying Drug for Noncrystal-Associated Osteoarthritis
por: Sun, Yubo, et al.
Publicado: (2013) -
Biological Activities of Phosphocitrate: A Potential Meniscal Protective Agent
por: Sun, Yubo, et al.
Publicado: (2013) -
The role of inhibition by phosphocitrate and its analogue in chondrocyte differentiation and subchondral bone advance in Hartley guinea pigs
por: Sun, Yubo, et al.
Publicado: (2018)